BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 38222111)

  • 1. Human iPSC modeling recapitulates
    Van Haver S; Fan Y; Bekaert SL; Everaert C; Van Loocke W; Zanzani V; Deschildre J; Maestre IF; Amaro A; Vermeirssen V; De Preter K; Zhou T; Kentsis A; Studer L; Speleman F; Roberts SS
    iScience; 2024 Jan; 27(1):108096. PubMed ID: 38222111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Pathological Activities of ALK in Neuroblastoma, a Neural Crest-Derived Cancer.
    Wulf AM; Moreno MM; Paka C; Rampasekova A; Liu KJ
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic lymphoma kinase (alk), a neuroblastoma associated gene, is expressed in neural crest domains during embryonic development of Xenopus.
    Moreno MM; Barrell WB; Godwin A; Guille M; Liu KJ
    Gene Expr Patterns; 2021 Jun; 40():119183. PubMed ID: 34020009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
    Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
    Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lineage-specific differentiation of osteogenic progenitors from pluripotent stem cells reveals the FGF1-RUNX2 association in neural crest-derived osteoprogenitors.
    Kidwai F; Mui BWH; Arora D; Iqbal K; Hockaday M; de Castro Diaz LF; Cherman N; Martin D; Myneni VD; Ahmad M; Futrega K; Ali S; Merling RK; Kaufman DS; Lee J; Robey PG
    Stem Cells; 2020 Sep; 38(9):1107-1123. PubMed ID: 32442326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type ALK and activating ALK-R1275Q and ALK-F1174L mutations upregulate Myc and initiate tumor formation in murine neural crest progenitor cells.
    Montavon G; Jauquier N; Coulon A; Peuchmaur M; Flahaut M; Bourloud KB; Yan P; Delattre O; Sommer L; Joseph JM; Janoueix-Lerosey I; Gross N; Mühlethaler-Mottet A
    Oncotarget; 2014 Jun; 5(12):4452-66. PubMed ID: 24947326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALK and GSK3: Shared Features of Neuroblastoma and Neural Crest Cells.
    Gonzalez Malagon SG; Liu KJ
    J Exp Neurosci; 2018; 12():1179069518792499. PubMed ID: 30127638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking neural crest development to neuroblastoma pathology.
    Gonzalez Malagon SG; Liu KJ
    Development; 2022 Aug; 149(15):. PubMed ID: 35905010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin.
    Kameneva P; Artemov AV; Kastriti ME; Faure L; Olsen TK; Otte J; Erickson A; Semsch B; Andersson ER; Ratz M; Frisén J; Tischler AS; de Krijger RR; Bouderlique T; Akkuratova N; Vorontsova M; Gusev O; Fried K; Sundström E; Mei S; Kogner P; Baryawno N; Kharchenko PV; Adameyko I
    Nat Genet; 2021 May; 53(5):694-706. PubMed ID: 33833454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ALK receptor in sympathetic neuron development and neuroblastoma.
    Janoueix-Lerosey I; Lopez-Delisle L; Delattre O; Rohrer H
    Cell Tissue Res; 2018 May; 372(2):325-337. PubMed ID: 29374774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
    Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
    J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia.
    Vivancos Stalin L; Gualandi M; Schulte JH; Renella R; Shakhova O; Mühlethaler-Mottet A
    Front Oncol; 2019; 9():275. PubMed ID: 31058082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma.
    Dong R; Yang R; Zhan Y; Lai HD; Ye CJ; Yao XY; Luo WQ; Cheng XM; Miao JJ; Wang JF; Liu BH; Liu XQ; Xie LL; Li Y; Zhang M; Chen L; Song WC; Qian W; Gao WQ; Tang YH; Shen CY; Jiang W; Chen G; Yao W; Dong KR; Xiao XM; Zheng S; Li K; Wang J
    Cancer Cell; 2020 Nov; 38(5):716-733.e6. PubMed ID: 32946775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroblastoma: When differentiation goes awry.
    Zeineldin M; Patel AG; Dyer MA
    Neuron; 2022 Sep; 110(18):2916-2928. PubMed ID: 35985323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting anaplastic lymphoma kinase in neuroblastoma.
    Umapathy G; Mendoza-Garcia P; Hallberg B; Palmer RH
    APMIS; 2019 May; 127(5):288-302. PubMed ID: 30803032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastoma models for insights into tumorigenesis and new therapies.
    Kiyonari S; Kadomatsu K
    Expert Opin Drug Discov; 2015 Jan; 10(1):53-62. PubMed ID: 25345447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cells.
    Fadeev A; Mendoza-Garcia P; Irion U; Guan J; Pfeifer K; Wiessner S; Serluca F; Singh AP; Nüsslein-Volhard C; Palmer RH
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E630-E638. PubMed ID: 29317532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.
    Vega FM; Colmenero-Repiso A; Gómez-Muñoz MA; Rodríguez-Prieto I; Aguilar-Morante D; Ramírez G; Márquez C; Cabello R; Pardal R
    EBioMedicine; 2019 Nov; 49():82-95. PubMed ID: 31685444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ALK as a major familial neuroblastoma predisposition gene.
    Mossé YP; Laudenslager M; Longo L; Cole KA; Wood A; Attiyeh EF; Laquaglia MJ; Sennett R; Lynch JE; Perri P; Laureys G; Speleman F; Kim C; Hou C; Hakonarson H; Torkamani A; Schork NJ; Brodeur GM; Tonini GP; Rappaport E; Devoto M; Maris JM
    Nature; 2008 Oct; 455(7215):930-5. PubMed ID: 18724359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of anaplastic lymphoma kinase in pediatric cancers.
    Takita J
    Cancer Sci; 2017 Oct; 108(10):1913-1920. PubMed ID: 28756644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.